Why are some muscular dystrophies grouped under LGMDs?
Limb girdle muscular dystrophy (LGMD) are inherited muscular dystrophies grouped under the label "limb girdle" because they generally affect the pelvic and shoulder girdles.
How many LGMD subtypes exist?
To date, over 20 types of LGMD are identified, each caused by mutations in a different gene. New subtypes continue to be discovered, so the current list is almost certainly incomplete. Each subtype has specific features, such as age of onset of symptoms, rate of progression, particular muscles involved, and whether there is heart and respiratory involvement. Because a large number of genes cause LGMD and variable clinical presentation, determining the specific type of LGMD of a particular patient is challenging.
Why is it important to determine the specific LGMD subtype?
It is vital for appropriate subtype specific monitoring (for example, cardiac or respiratory involvement in some subtypes) and any available therapy. Enrollment in clinical trials also requires information of the patientís specific type of LGMD.
How does the tool help to differentiate between the LGMD subtypes?
The tool predicts the most likely type(s) of LGMD a patient may have, based on clinical presentation and laboratory findings. This tool also provides recommendation about which molecular diagnostic tests (protein or genetic sequencing) are most likely to be informative to reach the final diagnosis for a particular patient.
How was the tool developed?
This subtype prediction tool was developed using a variety of data sources, including a thorough review of the medical literature on clinical presentations and diagnostic findings for various forms of LGMD, and consultation with diagnostic pathologists and clinical neurologists who specialize in research and diagnosis of muscular dystrophy.
What assumptions does the tool make?
ALDA assumes that the patient has one of the diseases included in the tool and will give a predicted percentage even if the patient has none of the listed diseases. Therefore, if the concordance score is medium-low or low, the patient may not have one of the listed diseases. In addition the tool assumes that neurogenic causes of muscular weakness (Spinal Muscular Atrophy, Charcot-Marie-Tooth, etc.) and autoimmune causes of muscle weakness have already been considered and excluded.
Are all distal muscular dystrophies covered in this tool?
Some types of LGMD present as distal muscular dystrophies. Although, this tool considers one of the more common forms of distal muscular dystrophy, Nonaka Distal Myopathy (aka HIBM2), it does not consider all of the currently-identified types of distal MD. A listing of currently-identified types of distal MD is given at http://neuromuscular.wustl.edu/musdist/distal.html.
Are all LGMD types identified by this tool?
New genetic types of LGMD continue to be identified. It is estimated that with current knowledge, about 75% of LGMD patients are able to be diagnosed with a specific type. Even for currently-identified types of LGMD, a number of case reports in the medical literature describe patients whose phenotypes are atypical, or outside the previously-reported spectrum of their particular form of LGMD. The tool may not be able to correctly diagnose patients whose symptoms are unusual or unreported for their type of LGMD.
What are the next steps in order to complete the diagnosis?
The ìgold standardî for diagnosis of a specific type of LGMD is identification of pathological mutations by genetic sequencing (on one allele for a dominant inheritance, on both alleles for a recessive inheritance). In some cases, testing at the protein level is desirable before proceeding to genetic sequencing. Thus, this tool's output should be considered a recommendation for which genes or proteins to consider in further testing, and not a diagnosis in itself.
Who should use this tool?
This tool is intended for use by trained clinicians. Its output is based on the typical clinical and laboratory findings for different genetic types of Limb-Girdle Muscular Dystrophy as described in the medical literature. The output is limited by the current state of knowledge, and no guarantees are made for its accuracy. The output of this tool is not a substitute for the physicianís medical judgment, or appropriate clinical evaluation and diagnostic tests.
I'm having technical problems, what do I do?
1. What browsers are supported by this tool?
ALDA supports Chrome, Internet Explorer 8 or above, Safari and Firefox. If you are using IE 7 or lower, we suggest that you install one of the supported browsers or use it from a computer with one of the supported browsers.
2. Probability chart is not showing up. What should I do?
Make sure you are using one of the supported browsers. Also make sure that you have enabled Javascript in your browser.
3. When I use the tool, my browser and computer slow down. What should I do?
We have been notified that this tool may slow down Firefox. If you encounter this issue, try using another supported browser.
4. Please email Elaine Lee if you have are having any other technical difficulties
I would like to give feedback or share my thoughts and opinions about the tool
Please fill out the Online Feedback Form